Real-World Data Show Total Neoadjuvant Therapy Boosts Tumor Response in Rectal Cancer
A large real-world cohort from Thailand finds that total neoadjuvant therapy doubles pathological complete response rates in locally advanced rectal ...
A large real-world cohort from Thailand finds that total neoadjuvant therapy doubles pathological complete response rates in locally advanced rectal ...
A study of 141 triple-negative breast cancer patients shows that advection terms in mathematical models best capture tumor cell movement ...
A stage IIIB lung squamous cell carcinoma patient achieved a pathological complete response after neoadjuvant sugemalimab plus chemotherapy, with biomarker ...
A phase II trial found that neoadjuvant camrelizumab plus apatinib, a chemotherapy-free combination of immunotherapy and anti-angiogenic therapy, produced manageable ...
A large Chinese multicenter study finds that 16.4 percent of locally advanced gastric cancer patients achieve a pathological complete response ...
An integrated single-cell and spatial transcriptomic study has identified a triple-negative breast cancer-enriched malignant epithelial program, EP5, linked to aggressive ...
A Phase III trial of 807 patients found the trastuzumab biosimilar EG12014 statistically equivalent to reference trastuzumab in efficacy, safety, ...
A new review argues that neoadjuvant chemoradiotherapy may induce immune checkpoint blockade responsiveness in mismatch repair-proficient rectal cancer, with sequential ...
A new commentary warns that the three-factor risk model proposed for esophageal cancer patients achieving pathological complete response after neoadjuvant ...
A multicentre Phase II trial found that neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil before transoral surgery allowed 91 percent ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine